These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 10934090)

  • 1. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
    Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
    Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
    Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.
    Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP
    Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
    Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
    Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
    Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
    J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
    Creticos P; Knobil K; Edwards LD; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):401-9. PubMed ID: 11991558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
    Brabson JH; Clifford D; Kerwin E; Raphael G; Pepsin PJ; Edwards LD; Srebro S; Rickard K
    Am J Med; 2002 Jul; 113(1):15-21. PubMed ID: 12106618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC; Brogden RN
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
    Nathan RA; Bleecker ER; Kalberg C;
    Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.
    Barnes NC; Miller CJ
    Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
    Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
    J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
    Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
    Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ; Hanby LA; Lavins BJ; Simonson SG
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.